Cardiovascular effects of approved drugs for rheumatoid arthritis

F Atzeni, J Rodríguez-Carrio, CD Popa… - Nature Reviews …, 2021 - nature.com
The risk of cardiovascular disease is increased in patients with rheumatoid arthritis
compared with the general population owing to the influence of traditional and non …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Burden of disease in treated rheumatoid arthritis patients: going beyond the joint

M Cutolo, GD Kitas, PLCM van Riel - Seminars in arthritis and rheumatism, 2014 - Elsevier
Objective The disease burden in rheumatoid arthritis (RA) extends beyond the joint. This
article evaluates the physical and psychosocial extra-articular burden of treated RA and …

Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis

EEA Arts, C Popa, AA Den Broeder, AG Semb… - Annals of the …, 2015 - ard.bmj.com
Objective This study was undertaken to assess the predictive ability of 4 established
cardiovascular (CV) risk models for the 10-year risk of fatal and non-fatal CV diseases in …

Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients

P Brito-Zerón, B Kostov, R Solans, G Fraile… - Annals of the …, 2016 - ard.bmj.com
Objective To score systemic activity at diagnosis and correlate baseline activity with survival
in a large cohort of patients with primary Sjögren syndrome (SS). Patients and methods We …

[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients

EEA Arts, J Fransen, AA den Broeder… - Annals of the …, 2015 - ard.bmj.com
Objective Disease duration and disease activity may be associated with an increased risk of
cardiovascular disease (CVD) in rheumatoid arthritis (RA). The objectives of this study were …

Comorbidities in rheumatoid arthritis

M Dougados - Current opinion in rheumatology, 2016 - journals.lww.com
Several comorbidities are frequently observed in rheumatoid arthritis because of the
persistent activity of the disease and/or because of the administered antirheumatic …

Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms

EEA Arts, CD Popa, AA Den Broeder… - Annals of the …, 2016 - ard.bmj.com
Objectives Predictive performance of cardiovascular disease (CVD) risk calculators appears
suboptimal in rheumatoid arthritis (RA). A disease-specific CVD risk algorithm may improve …

Autoimmune rheumatic diseases and vascular function: the concept of autoimmune atherosclerosis

AM Hedar, MH Stradner, A Roessler… - Journal of clinical …, 2021 - mdpi.com
Autoimmune rheumatic diseases (AIRDs) with unknown etiology are increasing in incidence
and prevalence. Up to 5% of the population is affected. AIRDs include rheumatoid arthritis …